YSB Inc
Company Profile
Business description
YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Group mainly engaged in i) wholesales of pharmaceutical and healthcare products offline or online through its online platform; ii) retail of pharmaceutical and healthcare products through its retail shops; iii) operating online platform that enable the pharmaceutical distributors and vendors to sell their own pharmaceutical and healthcare products using the Group’s online platform; iv) providing SaaS solution to downstream pharmacies to streamline their inventory management; and v) providing medical testing services to primary healthcare institutions. The Group principally operates in the PRC and generates the majority of its revenues from the PRC.
Contact
No. 8 Brand Street, No. 397 Xingang Middle Road
Yaoshibang Building
TIT Creative Industry Zone
Guangzhou
CHNT: +86 4001180958
Sector
Healthcare
Stock type
Defensive
Industry
Pharmaceutical Retailers
Fiscal Year End
31 December 2025
Employees
6,763
Stocks News & Analysis
stocks
Ask the analyst: Are Qantas shares a value trap?
stocks
Palantir earnings: Blockbuster growth amid high expectations
stocks
ResMed earnings: Solid showing from ASX healthcare winner
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,111.10 | 82.30 | 0.91% |
CAC 40 | 7,635.03 | 13.99 | 0.18% |
DAX 40 | 23,924.36 | 78.29 | 0.33% |
Dow JONES (US) | 44,204.67 | 92.93 | 0.21% |
FTSE 100 | 9,164.31 | 21.58 | 0.24% |
HKSE | 24,910.63 | 8.10 | 0.03% |
NASDAQ | 21,095.81 | 179.26 | 0.86% |
Nikkei 225 | 40,794.86 | 245.32 | 0.60% |
NZX 50 Index | 12,880.16 | 3.12 | 0.02% |
S&P 500 | 6,338.97 | 39.78 | 0.63% |
S&P/ASX 200 | 8,843.70 | 73.30 | 0.84% |
SSE Composite Index | 3,633.99 | 16.40 | 0.45% |